Lungpacer Medical, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lungpacer Medical, Inc.
A system using nerve stimulation to treat diaphragm atrophy in mechanical ventilation patients is the latest product to be granted EAP designation. FDA officials recently confirmed that 17 devices have been accepted to the expedited development pathway about a year after the program launched.
In Vivo briefly describes these recently founded companies: Acton Pharmaceuticals, AesRx, Lungpacer Medical, MAX Endoscopy, OtoKinetics and Thermalin Diabetes.
Clinical Trials Software. Personal Health's mission is to improve the efficiency of clinical trials, from clinical trial design through data collection and trial management to presentation of final results. The company developed an electronic patient diary, a body monitor which continuously collects physiological parameters from patients and a dynamic data access and communications program which links the patient, the central database and trial management personnel via the Internet.
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries
- Lungpacer Medical USA Inc.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.